R SCOTT GREER
CIK 1211703 · last filed 2025-10-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.44M
Companies
6
Total Filings
64
Lifetime Open-Market Net
-$3.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTR | Director | 303,574 | $59.38 | $18.03M | -$4.22M | 32 | 2025-10-01 |
| INGN | Director | 45,260 | $6.40 | $289.7K | $0 | 11 | 2021-05-12 |
| Sientra, Inc. (SIEN) Delisted | Director | 58,773 | $0.17 | $10.2K | $150.0K | 5 | 2018-06-07 |
| Aravive, Inc. (VSAR) Delisted | Director | 44,380 | — | — | $196.6K | 7 | 2017-12-22 |
| STEM | Director | 290,183 | $7.31 | $2.12M | $0 | 6 | 2016-01-05 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Director | 0 | — | — | $99.9K | 2 | 2015-05-06 |
Recent Filings · Page 5 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-09-17 | NKTR | Grant (A) | — | $0 | EDGAR |
| 2015-08-26 | INGN | Grant (A) | — | $0 | EDGAR |
| 2015-08-18 | Sientra, Inc. (SIEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-01 | Aravive, Inc. (VSAR) Delisted | Grant (A) | +4,575 | $0 | EDGAR |
| 2015-05-06 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Mixed | −7,190 | $0 | EDGAR |
| 2015-01-27 | Aravive, Inc. (VSAR) Delisted | Buy (P) | +5,500 | $94.9K | EDGAR |
| 2015-01-05 | STEM | Grant (A) | +58,253 | $0 | EDGAR |
| 2014-12-11 | Aravive, Inc. (VSAR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-25 | NKTR | Grant (A) | — | $0 | EDGAR |
| 2014-07-16 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Buy (P) | +5,190 | $99.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.